Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Is it time to modify the reverse cholesterol transport model?
Alan R. Tall, … , Nan Wang, Phillip Mucksavage
Alan R. Tall, … , Nan Wang, Phillip Mucksavage
Published November 1, 2001
Citation Information: J Clin Invest. 2001;108(9):1273-1275. https://doi.org/10.1172/JCI14342.
View: Text | PDF
Commentary

Is it time to modify the reverse cholesterol transport model?

  • Text
  • PDF
Abstract

Authors

Alan R. Tall, Nan Wang, Phillip Mucksavage

×

Total citations by year

Year: 2022 2021 2017 2016 2013 2011 2010 2009 2008 2007 2004 2002 Total
Citations: 1 1 1 1 1 1 2 1 1 2 1 2 15
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (15)

Title and authors Publication Year
Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review
D Goldberg, S Khatib, Q Yu
Oxidative Medicine & Cellular Longevity 2022
Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
N Kumar, CC Mandal
Frontiers in Genetics 2021
Erythrodiol, an Olive Oil Constituent, Increases the Half-Life of ABCA1 and Enhances Cholesterol Efflux from THP-1-Derived Macrophages
L Wang, S Wesemann, L Krenn, A Ladurner, EH Heiss, VM Dirsch, AG Atanasov
Frontiers in pharmacology 2017
Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages
L Wang, V Palme, S Rotter, N Schilcher, M Cukaj, D Wang, A Ladurner, EH Heiss, H Stangl, VM Dirsch, AG Atanasov
Molecular Nutrition & Food Research 2016
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
R Kones
Vascular Health and Risk Management 2013
A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol
S Sankaranarayanan, G Kellner-Weibel, M la Llera-Moya, MC Phillips, BF Asztalos, R Bittman, GH Rothblat
Journal of lipid research 2011
Future Therapeutic Directions in Reverse Cholesterol Transport
AV Khera, DJ Rader
Current Atherosclerosis Reports 2010
Design, Synthesis, and Biological Evaluation of Benzylamino-Methanone Based Cholesteryl Ester Transfer Protein Inhibitors
GA Sheikha, RA Khalaf, A Melhem, G Albadawi
Molecules (Basel, Switzerland) 2010
ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse
C Xie, SD Turley, JM Dietschy
Journal of lipid research 2009
Balancing cholesterol synthesis and absorption in the gastrointestinal tract
DE Cohen
Journal of Clinical Lipidology 2008
HDL proteomics: Pot of gold or Pandora's box?
Muredach P. Reilly1 and Alan R. Tall2
Journal of Clinical Investigation 2007
Will torcetrapib be the next big thing in coronary heart disease risk reduction?
JM McKenney, JA Hoekstra
Current Atherosclerosis Reports 2007
Intracerebroventricular leptin regulates hepatic cholesterol metabolism
S Vanpatten, GB Karkanias, L Rossetti, DE Cohen
Biochemical Journal 2004
Conway Memorial Lecture 2002 The dyslipidaemia of diabetes: lessons in the pathogenesis of atherosclerosis
GH Tomkin
Irish Journal of Medical Science 2002
A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta
Sean Ekins, Leonid Mirny, Erin G Schuetz
Pharmaceutical Research 2002

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts